Dr Robert Walsh obtained his undergraduate medical degree from the University of Cambridge, England before undertaking Foundation training at the University Hospitals of Leicester NHS Trust. He has worked in the Singapore health system since 2013 and obtained his postgraduate qualifications from the Royal College of Physicians (UK) in 2015. Dr Walsh subsequently completed postgraduate residency training in Internal Medicine and Medical Oncology at the National University Health System, Singapore. His areas of clinical and research interests include gastrointestinal cancer, genitourinary cancer, and precision oncology.
1. Population diversity in oncology drug responses and implications to drug development. Robert Walsh, Boon-Cher Goh. Chin Clin Oncol. 2019 Jun;8(3):24. doi: 10.21037/cco.2019.05.01
2. Resistance to immune checkpoint inhibitors in non-small cell lung cancer: biomarkers and therapeutic strategies. Robert J Walsh, Ross A Soo. Ther Adv Med Oncol. 2020 July 3. doi: 10.1177/1758835920937902.
3. The Role of Immunotherapy in the Treatment of Advanced Cervical Cancer: Current Status and Future Perspectives. Robert J Walsh, David SP Tan. Journal of Clinical Medicine. 2021
